Want to track CSBR and more in your Portfolio? 🎯
Sign up for Marketlog, a portfolio tracker that will exceed your expectations!
Champions Oncology, Inc. (CSBR) Statistics
Valuation metrics
Market Cap 79.43M
Enterprise value 88.14M
Trailing P/E (ttm) -39.57
Forward P/E 58
PEG ratio 0.3
Price/Sales (ttm) 1.56
Price/Book (mrq) 21.07
Enterprise Value/Revenue 1.52
Enterprise Value/EBITDA -92.97
Overview
Shares outstanding 13.89M
Float 5.19M
Shares short 81.89K
% Held by insiders 0.27%
% Held by institutions 0.48%
Average volume (10 days) 4.29K
Average volume (90 days) 9.5K
Price summary
52-Week low 5.5
52-Week high 9.63
Beta 0.4
50-Day moving average 6.03
200-Day moving average 6.3
Dividends and splits
Forward annual dividend rate -
Forward annual dividend yield -
Trailing annual dividend rate -
Trailing annual dividend yield -
5-Year annual dividend yield -
Payout ratio -
Dividend Date -
Ex-Dividend Date -
Last split factor 1:12
Last split Date 12 Aug 2015
Financials
Fiscal year
Fiscal year ends 30 Apr 2025
Most recent quarter (mrq) 31 Jan 2026
Profitability
Profit margin -0.04%
Operating margin -0.04%
Operational effectiveness
Return on assets -0.08%
Return on equity -0.58%
Income Statement
Revenue (ttm) 57.95M
Revenue per share (ttm) 4.17
Quarterly revenue growth (yoy) -0.03%
Gross profit (ttm) 26.58M
EBITDA 6.78M
Net income to common (ttm) -2.34M
Diluted EPS (ttm) -0.16
Quarterly earnings growth (yoy) -0.03%
Balance Sheet
Total cash (mrq) 7.13M
Total cash per share (mrq) 0.51
Total debt (mrq) 5M
Total Debt/Equity (mrq) 1.17
Current ratio (mrq) 0.98%
Book value per share (mrq) 0.32
Cash Flow
Cash flow statement 4.39M
Levered free cash flow (LFCF) 4.7M
